Pharmaceutical Business Intelligence

  • Formulary management
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

ADAPALENE Drug Profile

« Back to Dashboard

Which patents cover Adapalene, and what substitute generic drugs are available?

Adapalene is a drug marketed by Actavis Mid Atlantic, Glenmark Generics, Taro, Fougera Pharms, Pliva Hrvatska Doo, Call Inc, and Tolmar. and is included in nine NDAs.

The generic ingredient in ADAPALENE is adapalene; benzoyl peroxide. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the adapalene; benzoyl peroxide profile page.

Summary for Tradename: ADAPALENE

Suppliers / Packagers: see list12
Bulk Api Vendors: see list88
Clinical Trials: see list31
Patent Applications: see list1,896
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ADAPALENE at DailyMed

Pharmacology for Tradename: ADAPALENE

Drug ClassRetinoid
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic
GEL;TOPICAL201000-001Oct 27, 2014RXNoNo► Subscribe► Subscribe
Call Inc
SOLUTION;TOPICAL204593-001Jan 5, 2016RXNoYes► Subscribe► Subscribe
Fougera Pharms
CREAM;TOPICAL090824-001Jun 30, 2010RXNoNo► Subscribe► Subscribe
GEL;TOPICAL200298-001Jun 14, 2012RXNoNo► Subscribe► Subscribe
Glenmark Generics
GEL;TOPICAL091314-001Jul 1, 2010RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.